Two Methods of Lip Taping as a Presurgical Orthopedic Appliance
Launched by UNIVERSITY OF BAGHDAD · Mar 30, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of lip taping to see which one works better before surgery for infants with a condition called bilateral cleft lip and palate. Cleft lip and palate are birth defects that affect how the lip and mouth form. The goal is to find out which method helps improve the shape of the mouth area in babies before they have surgery.
To participate in this study, infants must be between 1 and 30 days old and have a complete bilateral cleft lip and palate, meaning both sides of the lip are affected. Unfortunately, babies with other health issues or different types of clefts cannot join. If you decide to participate, your baby will be monitored while using one of the lip taping methods, and this will help doctors learn more about how to improve treatment for future patients. The study is currently recruiting participants, and both boys and girls are welcome to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Non-Syndromic infants with complete bilateral cleft lip and palate.
- • 2. Both sexes.
- • 3. Age range from 1-30 day
- Exclusion Criteria:
- • 1. Infants with systemic syndromes.
- • 2. infants with unilateral cleft
- • 3. infants whom parents refuse to consent.
About University Of Baghdad
The University of Baghdad, a leading academic institution in Iraq, is committed to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive network of experts and state-of-the-art facilities to conduct rigorous clinical studies. The institution aims to contribute valuable insights into various health conditions, fostering an environment of scientific inquiry and ethical research practices that ultimately enhance patient care and public health in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, Al Rusaffa, Iraq
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials